Showing 1 to 10 of 19 Clinical Trials
|
CLINICAL TRIAL Trial No ClinicalTrials.gov ID |
Principal Investigator
Coordinator |
||
|---|---|---|---|
|
A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients With Germ Cell Tumors
COG-AGCT-1531 NCT03067181  Recruiting
|
CHU DE QUEBEC – UNIVERSITE LAVAL
CHUL ET CENTRE MERE-ENFANT SOLEIL
|
Pediatric |
Dr. Bruno Michon Barbara Desbiens 418-525-4444 poste 40195 |
|
Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients With Non-high-risk Neuroblastoma
COG-ANBL-1232 NCT02176967 Recruiting
|
CHU DE QUEBEC – UNIVERSITE LAVAL
CHUL ET CENTRE MERE-ENFANT SOLEIL
|
Pediatric |
Dr. Bruno Michon Marie-Christine Gagnon 418-525-4444 poste 40196 |
|
NMTT- Neuroblastoma Maintenance Therapy Trial Using Difluoromethylornithine (DFMO)
NMTRC014 NCT02679144 Recruiting
|
CHU DE QUEBEC – UNIVERSITE LAVAL
CHUL ET CENTRE MERE-ENFANT SOLEIL
|
Pediatric |
Dr. Bruno Michon Marie-Christine Gagnon 418-525-4444 poste 40196 |
|
Total Therapy for Infants With Acute Lymphoblastic Leukemia (ALL) I
TINI NCT02553460 Recruiting
|
CHU DE QUEBEC – UNIVERSITE LAVAL
CHUL ET CENTRE MERE-ENFANT SOLEIL
|
Pediatric |
Dr. Bruno Michon Marie-Christine Gagnon 418-525-4444 poste 40196 |
|
Health Related Quality of Life (HRQL) and Symptom Assessment in Patients Diagnosed With Diffuse Intrinsic Pontine Glioma (DIPG) or Recurrent and Re-irradiated Brain Tumours and Their Caregivers: A Non-Therapeutic Study
DIPG HRQOL NCT04670016 Recruiting
|
CHU DE QUEBEC – UNIVERSITE LAVAL
CHUL ET CENTRE MERE-ENFANT SOLEIL
|
Pediatric |
Dr. Valérie Larouche Panagiota Giannakouros 418-525-4444 poste 40121 |
|
Renal Tumors Classification, Biology, and Banking Study
COG-AREN03B2 NCT00898365 Recruiting
|
CHU DE QUEBEC – UNIVERSITE LAVAL
CHUL ET CENTRE MERE-ENFANT SOLEIL
|
Pediatric |
Dr. Bruno Michon Marie-Christine Gagnon 418-525-4444 poste 40196 |
|
Personalized Targeted Therapy in Refractory or Relapsed Cancer in Childhood(TRICEPS Study)
TRICEPS NCT02242552 Recruiting
|
CHU DE QUEBEC – UNIVERSITE LAVAL
CHUL ET CENTRE MERE-ENFANT SOLEIL
|
Pediatric |
Dr. Bruno Michon Barbara Desbiens 418-525-4444 poste 40195 Marie-Christine Gagnon 418-525-4444 poste 40196 |
|
Phase II Trial of Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma
BCC015 NCT04301843 Recruiting
|
CHU DE QUEBEC – UNIVERSITE LAVAL
CHUL ET CENTRE MERE-ENFANT SOLEIL
|
Pediatric |
Dr. Lamia Naccache Émilie Martineau 418-525-4444 poste 40121 |
|
A Phase 2, Open-Label, Multicenter Study to Evaluate the Safety and Efficacy of the Oral Pan-RAF Inhibitor DAY101 in Pediatric Patients With BRAF-Altered, Recurrent or Progressive Low-Grade Glioma
FIREFLY-1 NCT04775485 Recruiting
|
CHU DE QUEBEC – UNIVERSITE LAVAL
CHUL ET CENTRE MERE-ENFANT SOLEIL
|
Pediatric |
Dr. Valérie Larouche Panagiota Giannakouros 418-525-4444 poste 40121 |
|
A Phase II Canadian Pediatric Brain Tumour Consortium Study of Re-Irradiation as Treatment of Progressive or Recurrent Diffuse Intrinsic Pontine Glioma
ReRad NCT03126266 Recruiting
|
CHU DE QUEBEC – UNIVERSITE LAVAL
L'HOTEL-DIEU DE QUEBEC ET CRCEO
|
Pediatric |
Dr. Valérie Larouche Panagiota Giannakouros 418-525-4444 poste 40121 |
Groupe d'étude en oncologie du Québec